Data & Analytics

Branded Legacy just wiped out $1M in legacy debt. The move is part of a radical overhaul by new management aimed at rebuilding investor confidence.

The AI investment frenzy is shifting from GPUs to the physical world of power, cooling, and real estate, creating a new class of high-value companies.

Industrial giant Fastenal partners with the Belfast Giants, a strategic move blending global business ambition with deep-rooted community engagement in NI.

Asia Pacific Wire & Cable is raising $33.9M via a rights offer to fund its US expansion. Shareholders must now weigh participation against dilution risk.

A major foundation is investing $75.8M to build a responsible public architecture for AI, funding projects that prioritize human rights and global equity.

Creekstone Energy plans to add 2 gigawatts of nuclear power to its Utah Gigasite, a bold move to satisfy AI's insatiable energy appetite.

Financial Institutions, Inc. executes a savvy debt refinancing, cutting costs by over $1M annually and fortifying its balance sheet for future growth.

PG&E's new grid tech does more than keep lights on; it's a vital upgrade for healthcare resilience, wildfire prevention, and safety in a changing climate.

A new class of AI-driven blood tests can detect lung cancer recurrence years before imaging, shaking up patient care and the multi-billion dollar diagnostics market.

A new inflation metric from Numerator does more than track prices; it signals a new era where private firms provide strategic economic intelligence.

Canadian grocer Empire posts strong sales but lower earnings. A deep dive into its dual strategy of store renewal and a major digital and data overhaul.

A new contract for TGS in Brazil signals enduring appeal for offshore oil. Discover how 4D seismic is unlocking value in mature, complex energy fields.

Tariff relief was a temporary fix. A powerful federal tax credit offers farmers a sustained way to fund the innovation they perform every day.

While the container market faces a glut, Euroseas locks in 3-year deals, showcasing a masterclass in strategic foresight and financial resilience.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

Black Friday’s record-breaking data demands reveal a blueprint for healthcare's own looming data crisis. What can medicine learn from retail's tech engine?

An Austin firm’s massive growth to $30B AUM reveals a key trend: specialized asset managers are becoming the new architects of our connected future.

A.D.A.M. Innovations just launched ALUNAÉ, the world's first AI genomic-based skincare. Is this the future of beauty or a step too far?

Tempus AI's research at a key symposium shows its AI-driven edge, turning vast patient data into a powerful asset that could reshape oncology and investor outlooks.

A new alliance explores how inanimate microbes, or postbiotics, could become a novel weapon in oncology, starting with breast cancer research.